Related Experiment Video

Updated: Nov 27, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.8K

Globus pallidus internus deep brain stimulation in PINK-1 related Parkinson's disease: An update

Linda Borellini1, Filippo Cogiamanian1, Gianluca Ardolino1

  • 1Neuropathophysiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore, Policlinico, Milan, Italy.

Parkinsonism & Related Disorders
|December 4, 2020
PubMed
Abstract

No abstract available in PubMed .

Keywords:
AutosomalDeep brain stimulationPINK-1Parkinson's diseaseRecessive Parkinson's disease

More Related Videos

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
07:14

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

Published on: May 31, 2016

15.1K
Microelectrode Guided Implantation of Electrodes into the Subthalamic Nucleus of Rats for Long-term Deep Brain Stimulation
10:52

Microelectrode Guided Implantation of Electrodes into the Subthalamic Nucleus of Rats for Long-term Deep Brain Stimulation

Published on: October 2, 2015

20.2K

Related Experiment Videos

Last Updated: Nov 27, 2025

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.8K
A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
07:14

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

Published on: May 31, 2016

15.1K
Microelectrode Guided Implantation of Electrodes into the Subthalamic Nucleus of Rats for Long-term Deep Brain Stimulation
10:52

Microelectrode Guided Implantation of Electrodes into the Subthalamic Nucleus of Rats for Long-term Deep Brain Stimulation

Published on: October 2, 2015

20.2K

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

770
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
770
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.3K
Neural Regulation01:37

Neural Regulation

42.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.3K

Articles linked to this work by shared authors, journal, and citation graph.

Exploring the effects of cerebellar tDCS on mental rotation.

Cognitive processing·2026

Psychosocial and body image alterations associated with focal dystonia.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Clinical usability of telephone-based cognitive screening tests in Parkinson's disease.

Journal of Parkinson's disease·2026

Two faces of chronic pain: distinct psychosocial profiles in headache and fibromyalgia.

Clinical and experimental rheumatology·2026

Perilead Edema in Deep Brain Stimulation: Long-Term Outcomes and Etiologic Correlates.

Neuromodulation : journal of the International Neuromodulation Society·2025

Long-Term Motor and Cognitive Outcome of Deep Brain Stimulation in Patients With Parkinson Disease With a GBA1 Pathogenic Variant.

Neurology·2025

Consensus practice recommendations for management of sleep dysfunction in Parkinson disease.

Parkinsonism & related disorders·2026

Different psychological and quality-of-life outcomes after subthalamic nucleus deep brain stimulation in Parkinson's disease patients: a prospective study.

Parkinsonism & related disorders·2026

Elevated primary motor cortex GABA in Parkinson's disease: 7T MR spectroscopy evidence.

Parkinsonism & related disorders·2026

Genetic context unmasks olfactory loss as a marker for dyskinesia risk via levodopa exposure trajectories in Parkinson's disease.

Parkinsonism & related disorders·2026

Factors associated with suicidal ideation in people with parkinsonism: findings from the PRIME-UK cross-sectional study.

Parkinsonism & related disorders·2026

Parkinson's disease cognitive rehabilitation of executive functioning (PD-CoRE): A community-based intervention study.

Parkinsonism & related disorders·2026

Impulse Control Disorders Are Independent of Parkinson Disease Motor Subtypes.

medRxiv : the preprint server for health sciences·2026

Neuroinflammation-associated thalamocortical functional connectivity and cognition in older adults.

Journal of neuroinflammation·2026

Neuroglobin positively regulates YTHDF3 to restore mitophagy and suppress ferroptosis in sevoflurane-induced developmental neurotoxicity.

Chemico-biological interactions·2026

Repetitive nerve stimulation in juvenile myasthenia gravis: Diagnostic strategy and area decrement value.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2026

Non-canonical modulation of mitochondrial ROS and dynamics by Netrin-3 drives inflammasome activation in cardiomyocytes.

International immunopharmacology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us